| [1] |
|
|
Song Z P, Yuan R, Wang Y C. Investigation on aflatoxin contamination in commercially available foods in Huzhou City,2023[J]. Chinese Journal of Food Hygiene, 2025, 37(4):348-353.
|
| [2] |
|
|
Zhao L Y, Qin Y C, Zhang J M, Yu Y N. Research progress of rapid detection technology of common mycotoxins in feed meterials[J]. Chinese Journal of Animal Nutrition, 2025, 37(5):2911-2921.
|
| [3] |
|
|
Zhang L, Han R B, Shen J X, Wang X, Bao Y Z, Shi W Y. Research progress on toxicokinetics and toxic effects of aflatoxin B1[J]. Chinese Journal of Veterinary Medicine, 2025, 61(4):96-103.
|
| [4] |
|
|
An T H. The mechanism of oxidative stress and inflammatory response in liver injury of rats caused by AFB1 contamination under high-fat diet[D]. Daqing: Heilongjiang Bayi Agricultural University,2025.
|
| [5] |
韩佩宇, 车琳, 陈圆圆, 江珊, 段军燕, 孙宝芳, 何承勇, 林育纯, 林忠宁. CRISPR/Cas9敲低环氧合酶2表达对黄曲霉毒素B1诱导肝细胞核DNA损伤与脂质蓄积的影响[J]. 厦门大学学报(自然科学版), 2018, 57(5):634-642.doi: 10.6043/j.issn.0438-0479.201803016.
|
|
Han P Y, Che L, Chen Y Y, Jiang S, Duan J Y, Sun B F, He C Y, Lin Y C, Lin Z N. Effects of cyclooxygenase 2 knockdown using CRISPR/Cas9 on nuclear DNA damage and lipid accumulation in aflatoxin B1-induced hepatocytes[J]. Journal of Xiamen University(Natural Science), 2018, 57(5):634-642.
|
| [6] |
邱杨, 王冬梅, 昌冲, 李宜珂, 周腾建, 刘衡川, 何承勇, 林育纯, 林忠宁. AFB1对诱导分化肝HepaRG细胞的毒性损伤效应[C]. 中国毒理学会,湖北省科学技术协会.中国毒理学会第七次全国毒理学大会暨第八届湖北科技论坛论文集. 厦门大学分子疫苗学和分子诊断学国家重点实验室公共卫生学院,2015:273.
|
|
Qiu Y, Wang D M, Chang C, Li Y K, Zhou T J, Liu H C, He C Y, Lin Y C, Lin Z N. Toxic injury effects of AFB1 on differentiated HepaRG cells[C]. Chinese Society of Toxicology,Hubei Association for Science and Technology.The 7th National Congress of Toxicology,Chinese Society of Toxicology and the 8th Hubei Science and Technology Forum.State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,School of Public Health, Xiamen University,2015:273.
|
| [7] |
Zhu Q, Ma Y R, Liang J B, Wei Z W, Li M, Zhang Y, Liu M, He H, Qu C F, Cai J Q, Wang X B, Zeng Y X, Jiao Y C. AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma[J]. Signal Transduction and Targeted Therapy, 2021(1):2583-2595.doi: 10.1038/s41392-021-00713-1.
|
| [8] |
|
|
Zhu Q.Part I: Study on AHR-mediated toxicity of aflatoxin B1 in hepatocellular carcinoma;Part Ⅱ:analysis of EBV integration sites in multiple EBV-associated malignancies by targeted sequencing[D]. Beijing: Peking Union Medical College Hospital, 2021.
|
| [9] |
于明弘, 王萌, 葛冰洁, 闫可心, 王巍, 刘馨蔓, 刘晓童, 邱谦, 桑锐, 张雪梅. 蒲公英甾醇对AFB1诱导鸡原代肝细胞凋亡和自噬的影响[J]. 中国畜牧兽医, 2024, 51(9):3762-3770.doi: 10.16431/j.cnki.1671-7236.2024.09.006.
|
|
Yu M H, Wang M, Ge B J, Yan K X, Wang W, Liu X M, Liu X T, Qiu Q, Sang R, Zhang X M. Effect of taraxasterol on apoptosis and autophagy of chicken primary hepatocytes induced by AFB1[J]. China Animal Husbandry and Veterinary Medicine, 2024, 51(9):3762-3770.
|
| [10] |
张霞, 王涛, 张全美, 严光文, 安凤霞, 卢宝伟, 葛凯, 夏伦斌, 毕少帅. 酵母硒缓解黄曲霉毒素B1(AFB1) 诱导的鹌鹑肝脏损伤效果研究[J]. 安徽农学通报, 2025, 31(9):80-86.doi: 10.16377/j.cnki.issn1007-7731.2025.09.018.
|
|
Zhang X, Wang T, Zhang Q M, Yan G W, An F X, Lu B W, Ge K, Xia L B, Bi S S. Study on the effect of yest selenium in alleviating liver injury induced by aflatoxin B1 in quails[J]. Anhui Agricultural Science Bulletin, 2025, 31(9):80-86.
|
| [11] |
Wang R K, Zhang Q, Chen G, Kou R R, Zhang C Q, Wang Y H, Wang J, Huang Y Q, Chen C. Mechanistic insights into ferroptosis and apoptosis pathways:synergistic effects of multi-organ toxicity and transgenerational effects induced by co-exposure of epoxiconazole and aflatoxin B1 in zebrafish[J]. Journal of Advanced Research, 2025, 77:155-172.doi: 10.1016/j.jare.2025.01.020.
URL
|
| [12] |
Susukida T, Sekine S, Nozaki M, Tokizono M, Oizumi K, Horie T, Ito K. Establishment of a drug-induced,bile acid dependent hepatotoxicity model using HepaRG cells[J]. Journal of Pharmaceutical Sciences, 2016, 105(4):1550-1560.doi: 10.1016/j.xphs.2016.01.013.
pmid: 26952880
|
| [13] |
Ramaiahgari S C, den Braver M W, Herpers B, Terpstra V, Commandeur J N M, van de Water B, Price L S. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies[J]. Archives of Toxicology, 2014, 88(5):1083-1095.doi: 10.1007/s00204-014-1215-9.
pmid: 24599296
|
| [14] |
Pfeifer A M, Cole K E, Smoot D T, Weston A, Groopman J D, Shields P G, Vignaud J M, Juillerat M, Lipsky M M, Trump B F. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens[J]. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90(11):5123-5127.doi: 10.1073/pnas.90.11.5123.
pmid: 7685115
|
| [15] |
Parween S, Fernández-Cancio M, Benito-Sanz S, Camats N, Rojas Velazquez M N, López-Siguero J P, Udhane S S, Kagawa N, Flück C E, Audí L, Pandey A V. Molecular basis of CYP19A1 deficiency in a 46,XX patient with R550W mutation in POR:expanding the PORD phenotype[J]. The Journal of Clinical Endocrinology & Metabolism, 2020, 105(4):e1272-e1290.doi: 10.1210/clinem/dgaa076.
URL
|
| [16] |
Deng J, Yang J C, Feng Y, Xu Z J, Kucˇa K, Liu M, Sun L H. AP-1 and SP1 trans-activate the expression of hepatic CYP1A1 and CYP2A6 in the bioactivation of AFB1 in chicken[J]. Science China Life Sciences, 2024, 67(7):1468-1478.doi: 10.1007/s11427-023-2512-6.
|
| [17] |
Jiang H R, Wu J, Zhang F Y, Wen J K, Jiang J, Deng Y Q. The critical role of porcine cytochrome P450 3A46 in the bioactivation of aflatoxin B1[J]. Biochemical Pharmacology, 2018, 156:177-185.doi: 10.1016/j.bcp.2018.08.030.
pmid: 30142320
|
| [18] |
Rojas Velazquez M N R, Noebauer M, Pandey A V. Loss of protein stability and function caused by P228L variation in NADPH-cytochrome P450 reductase linked to lower testosterone levels[J]. International Journal of Molecular Sciences, 2022, 23(17):10141.doi: 10.3390/ijms231710141.
URL
|
| [19] |
Gong L, Zhang C M, Lyu J F, Zhou H H, Fan L. Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy[J]. Pharmacogenetics and Genomics, 2017, 27(9):337-346.doi: 10.1097/fpc.0000000000000297.
pmid: 28731962
|
| [20] |
Gao L C, Liu F Q, Yang L, Cheng L, Dai H Y, Tao R, Cao S P, Wang D, Tang J. The P450 oxidoreductase(POR)rs2868177 and cytochrome P450(CYP)2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity[J]. European Journal of Clinical Pharmacology, 2016, 72(10):1205-1213.doi: 10.1007/s00228-016-2095-0.
pmid: 27439448
|
| [21] |
孙莉, 陆定艳, 刘欢, 何俊奇, 孙佳, 王永林, 李勇军, 杨畅, 刘亭. 稳定表达CYP2A13和CYP2A13/POR的Flp-In CHO重组细胞系的构建[J]. 中国药理学通报, 2022, 38(5):795-799.doi: 10.12360/CPB202106094.
|
|
Sun L, Lu D Y, Liu H, He J Q, Sun J, Wang Y L, Li Y J, Yang C, Liu T. Establishment of Flp-In CHO recombinant cell lines stably expressing CYP2A13 and CYP2A13/POR[J]. Chinese Pharmacological Bulletin, 2022, 38(5):795-799.
|
| [22] |
|
|
Wang L, Yuan J L, Miao C, Ma Y H, Cao S J, Zhao Q. Construction of POR gene knockout,complementation,and overexpression LO2 cell lines and preliminary application as AFB1 exposed model[J]. Acta Agriculturae Zhejiangensis, 2024, 36(2):272-283.
|
| [23] |
Reed L, Jarvis I W H, Phillips D H, Arlt V M. Deletion of cytochrome P 450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells[J]. Mutagenesis, 2019, 34(5/6):413-420.doi: 10.1093/mutage/gez033.
|
| [24] |
Reed L, Mrizova I, Barta F, Indra R, Moserova M, Kopka K, Schmeiser H H, Wolf C R, Henderson C J, Stiborova M, Phillips D H, Arlt V M. Cytochrome b5impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation:studies in hepatic cytochrome b5/P450 reductase null(HBRN)mice[J]. Archives of Toxicology, 2018, 92(4):1625-1638.doi: 10.1007/s00204-018-2162-7.
|
| [25] |
Kannan S, Altae-Tran H, Zhu S Y, Xu P Y, Strebinger D, Oshiro R, Faure G, Moeller L, Pham J, Mears K S, Ni H M, MacRae R K, Zhang F. Evolution-guided protein design of IscB for persistent epigenome editing in vivo[J]. Nature Biotechnology, 2025.doi: 10.1038/s41587-025-02655-3.
|
| [26] |
Han J L, Yu B, Jing J N, He X Y, Hua Y F, Xu G T. EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers[J]. Cellular Oncology, 2025, 48(5):1317-1335.doi: 10.1007/s13402-025-01075-4.
|
| [27] |
Imburgia C, Organick L, Zhang K R, Cardozo N, McBride J, Bee C, Wilde D, Roote G, Jorgensen S, Ward D, Anderson C, Strauss K, Ceze L, Nivala J. Random access and semantic search in DNA data storage enabled by Cas9 and machine-guided design[J]. Nature Communications, 2025, 16:6388.doi: 10.1038/s41467-025-61264-5.
|
| [28] |
Li L J, Zhang D Q, Zhang Z Y, Zhang B H. CRISPR/Cas:a powerful tool for designing and improving oil crops[J]. Trends in Biotechnology, 2025, 43(4):773-789.doi: 10.1016/j.tibtech.2024.09.007.
URL
|
| [29] |
Tian Y, Bao X, Lei S, Huang Y C, Wang X L, Tu Y Y, He Q L, Zhang F X, Xu H C, Ashrafizadeh M, Sethi G, Wang F R, Zeng Z R. In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling[J]. Cell Communication and Signaling, 2025, 23(1):329.doi: 10.1186/s12964-025-02285-x.
pmid: 40634958
|
| [30] |
|
|
Wang W Y, Yuan Y L, Li L, Wang Y, Dai Y F, Yang H Y. Establishment of PIN1 knockout porcine fetal fibroblast cell lines via CRISPR/Cas9 mediated gene-targeting[J]. Academic Journal of Army Medical University, 2022, 44(13):1349-1355.
|
| [31] |
|
|
Xu D Y, Zhang W L, Zuo Y D, Su Z. Construction of a myocardial and skeletal muscle-specific Cyr61 gene knockout mouse model[J]. Basic & Clinical Medicine, 2025, 45(6):720-726.
|
| [32] |
|
|
Du X, Liu T. Research progress on effects of CYP450 oxidoreductase gene polymorphism on CYP enzyme[J]. Evaluation and Analysis of Drug-Use in Hospitals of China, 2016, 16(12):1725-1728.
|
| [33] |
Naldi G D A R, Minari A B, Pereira T D M, Fossaluza V, Eugenio N W, Ferreira M A, Gregório G H, Nacif L, D Albuquerque L A C, di Lazzaro Filho R, Cançado E L R, Ono S K. CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus-a cohort study[J]. The Pharmacogenomics Journal, 2025, 25(1/2):4.doi: 10.1038/s41397-025-00363-4.
|
| [34] |
Zou Y L, Li H X, Graham E T, Deik A A, Eaton J K, Wang W Y, Sandoval-Gomez G, Clish C B, Doench J G, Schreiber S L. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J]. Nature Chemical Biology, 2020, 16(3):302-309.doi: 10.1038/s41589-020-0472-6.
pmid: 32080622
|
| [35] |
Che L, Huang J, Lin J X, Xu C Y, Wu X M, Du Z B, Wu J S, Lin Z N, Lin Y C. Aflatoxin B1 exposure triggers hepatic lipotoxicity via p53 and perilipin 2 interaction-mediated mitochondria-lipid droplet contacts:an in vitro and in vivo assessment[J]. Journal of Hazardous Materials, 2023, 445:130584.doi: 10.1016/j.jhazmat.2022.130584.
URL
|
| [36] |
张晶晶, 邵超, 陆小军, 叶奕菁. 半枝莲对AFB1致肝细胞凋亡及脂质过氧化损伤的保护作用[J]. 药物与人, 2014, 27(5):2-3.
|
|
Zhang J J, Shao C, Lu X J, Ye Y Q. Inhibitory effect of Scutellaria barbata extract on hepatocytes apoptosis and lipid peroxidation induced by aflatoxin B1[J]. Medicine and People, 2014, 27(5):2-3.
|
| [37] |
|
|
Li L, Zhang G Y. Protective effect of quercetin against the toxicity of aflatoxin B1 toward buffalorat liver cells[J]. Science and Technology of Food Industry, 2018, 39(13):117-121,127.
|
| [38] |
|
|
Yu H, Yu Y Q, Qian T B, Liu Q Y, Wang Y, Zeng Z, Hu Z Q. Effects of aflatoxin B1 on the biophysical properties and cytoskeleton structure of hepatocellular carcinoma cell line HepG2[J]. Acta Universitatis Medicinalis Anhui, 2023, 58(1):10-14.
|
| [39] |
|
|
Li W Z, Zhang G Y, Sang Y Q. Co-effect cytotoxicity and mechanism research of deoxynivalenol and aflatoxin B1 in HepG2/C3A cells[J]. Journal of Food Science and Biotechnology, 2017, 36(11):1171-1179.
|
| [40] |
Ma X Y, Sun J D, Ye Y L, Ji J, Sun X L. Application of triple co-cultured cell spheroid model for exploring hepatotoxicity and metabolic pathway of AFB1[J]. Science of the Total Environment, 2022, 807:150840.doi: 10.1016/j.scitotenv.2021.150840.
URL
|